CONNEQT Health Limited (ASX:CQT)
Australia · Delayed Price · Currency is AUD 0.0450
0.00 (0.00%)
At close: Feb 5, 2026
CONNEQT Health Revenue
In the fiscal year ending June 30, 2025, CONNEQT Health had annual revenue of 6.05M AUD, down -52.76%. CONNEQT Health had revenue of 2.76M in the half year ending June 30, 2025, a decrease of -26.92%.
Revenue
6.05M
Revenue Growth
-52.76%
P/S Ratio
4.55
Revenue / Employee
n/a
Employees
n/a
Market Cap
27.56M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 6.05M | -6.76M | -52.76% |
| Jun 30, 2024 | 12.81M | 7.12M | 125.14% |
| Jun 30, 2023 | 5.69M | 953.17K | 20.12% |
| Jun 30, 2022 | 4.74M | -778.57K | -14.11% |
| Jun 30, 2021 | 5.52M | 738.20K | 15.45% |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Nova Eye Medical | 29.27M |
| CleanSpace Holdings | 19.76M |
| Micro-X | 13.05M |
| ImpediMed | 12.72M |
| CurveBeam AI | 12.10M |
| Control Bionics | 6.14M |
| Atomo Diagnostics | 3.79M |
| OncoSil Medical | 1.54M |